Login

Securities are offered through IFP Securities, LLC, while AmeriCorps' CEO shares key remarks in a separate discussion. 00:10:00

Share On Facebook Share On Twitter

William Hamm, CFA, CFP®, CLU. Chief Executive Officer 

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
CapMan's Strategic Updates and Ambitious Growth Targets Discussed by CEO Joakim Frimodig | Joakim Frimodig, CEO, CapMan.
00:10:00
Unified Self-Service Platform: Book, Stay, Use & Pay |Gijs van Lookeren Campagne, CO-CEO of ease2pay nv
00:10:00
Nuclear Fuels: U.S. Focused Uranium Exploration and Production Pathway in Wyoming
00:10:00
Rabobank's Robust Financial Results and Sustainability Initiatives | Wiebe Draijer, CEO, Rabobank.
00:10:00
State Management Deep Dive: Redux, NgRx, Signal Store, Context & Zustand | Jo Maes, CEO of Ordina NV
00:10:00
Key Principles of Tax Planning for Retirement | PAUL STAIB - CFP of Staib Financial Planning, LLC
00:10:00
Buchan Wealth Management Limited and Bouchey Financial Group, Ltd. are distinct entities renowned for their expertise in personalized wealth management strategies.
00:10:00
The Business of Fashion|Natalie Massenet,Co-Founder & Partner,Imaginary Ventures
00:00:00
SenzaGen CEO Peter Nählstedt presents the company at Vator Securities Healthcare Innovation Summit - Peter Nählstedt President and CEO, SenzaGen
00:10:00
Innovation knows no bounds and opportunity beckons with every launch|Dan Kimerling,Managing Partner, Deciens Capital
00:10:00
ROCA Industry’s Ionuț Bindea Discusses Market Dynamics and Growth Potential | Ionuț Bindea, CEO, ROCA Industry Holdingrock1 SA.
00:10:00
Dr. Bret Weinstein shares insights on "The Diary Of A CEO" podcast, while Peter Kaufman discusses M&A strategies in his Gordian Group LLC interview on M&A TV.

© 2026 Nehu